Delivery Order SPE2DB20D2014-SPE2DB24FA94K
- Not listed
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/ml pens, a medication used for the treatment of migraines. The contract has a ceiling value of $1,124.81 and runs through February 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and...
- This federal contract award, valued at $1,997.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product Emgality 120 mg/ml penml, a medication used for the treatment of migraines. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.51 firm-fixed-price contract is for the delivery of Emgality 120 mg/ml pens, a specialty medication used to treat migraines. The award was not set aside for any specific business category. The contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The award, valued at $7,852.63, is for the delivery of Emgality 120 mg/ml pen injectors, a medication used to treat migraines. The contract is a Firm Fixed Price Delivery Order with a completion date of December 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,804.17 firm fixed-price delivery order is for the supply of Emgality 120 mg/mL pen injectors, a medication used to treat migraines. The award is not associated with a set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,074.80 contract is for the supply of Emgality 120 mg/mL pens, a medication used to treat migraines. The award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,642.29 firm-fixed-price delivery order is for the supply of Emgality 120 mg/ml pen-injectors, a prescription medication used for the treatment of migraine. The award has an ultimate completion date of November 13, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
- This is a $3,008.16 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Emgality 120 mg/ml pen injectors, a medication used to treat migraine. The award has a period of performance through September 12, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,969.14 firm-fixed-price delivery order covers the supply of Emgality 120 mg/ml pen to DLA. The contract has an ultimate completion date of November 29, 2023 and was awarded on November 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Emgality 120 mg/ml Penml, a medication used to treat migraine. The award has a ceiling value of $1,383.20 and a period of performance through March 31, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA94KDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,359.94, is for the delivery of Emgality 120 mg/ml Penml, a medication used for the treatment of migraines. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 1/30/24 |